These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 11797789

  • 1. West Nile virus envelope protein: role in diagnosis and immunity.
    Wang T, Anderson JF, Magnarelli LA, Bushmich S, Wong S, Koski RA, Fikrig E.
    Ann N Y Acad Sci; 2001 Dec; 951():325-7. PubMed ID: 11797789
    [Abstract] [Full Text] [Related]

  • 2. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
    Ledizet M, Kar K, Foellmer HG, Bonafé N, Anthony KG, Gould LH, Bushmich SL, Fikrig E, Koski RA.
    J Infect Dis; 2007 Dec 15; 196(12):1741-8. PubMed ID: 18190253
    [Abstract] [Full Text] [Related]

  • 3. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, Price A, Jacobs A, Takahashi VN, Huang Y, Nakaar V, Alexopoulou L, Fikrig E, Powell TJ.
    J Infect Dis; 2007 Jun 01; 195(11):1607-17. PubMed ID: 17471430
    [Abstract] [Full Text] [Related]

  • 4. A recombinant envelope protein vaccine against West Nile virus.
    Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, Fikrig E, Koski RA.
    Vaccine; 2005 Jun 10; 23(30):3915-24. PubMed ID: 15917113
    [Abstract] [Full Text] [Related]

  • 5. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
    Schneeweiss A, Chabierski S, Salomo M, Delaroque N, Al-Robaiy S, Grunwald T, Bürki K, Liebert UG, Ulbert S.
    Vaccine; 2011 Aug 26; 29(37):6352-7. PubMed ID: 21596075
    [Abstract] [Full Text] [Related]

  • 6. A recombinant envelope protein-based enzyme-linked immunosorbent assay for West Nile virus serodiagnosis.
    Wang T, Magnarelli LA, Anderson JF, Gould LH, Bushmich SL, Wong SJ, Fikrig E.
    Vector Borne Zoonotic Dis; 2002 Aug 26; 2(2):105-9. PubMed ID: 12653304
    [Abstract] [Full Text] [Related]

  • 7. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.
    Alonso-Padilla J, de Oya NJ, Blázquez AB, Escribano-Romero E, Escribano JM, Saiz JC.
    Vaccine; 2011 Feb 17; 29(9):1830-5. PubMed ID: 21211580
    [Abstract] [Full Text] [Related]

  • 8. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F.
    J Infect Dis; 2005 Jan 15; 191(2):207-14. PubMed ID: 15609230
    [Abstract] [Full Text] [Related]

  • 9. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
    Throsby M, Ter Meulen J, Geuijen C, Goudsmit J, de Kruif J.
    Expert Rev Vaccines; 2007 Apr 15; 6(2):183-91. PubMed ID: 17408368
    [Abstract] [Full Text] [Related]

  • 10. Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.
    Li SH, Li XF, Zhao H, Jiang T, Deng YQ, Yu XD, Zhu QY, Qin ED, Qin CF.
    Immunol Lett; 2011 Aug 30; 138(2):156-60. PubMed ID: 21515306
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of an enzyme-linked immunosorbent assay for detection of West Nile virus infection based on a recombinant envelope protein produced in Trichoplusia ni larvae.
    Alonso-Padilla J, Jiménez de Oya N, Blázquez AB, Loza-Rubio E, Escribano JM, Saiz JC, Escribano-Romero E.
    J Virol Methods; 2010 Jun 30; 166(1-2):37-41. PubMed ID: 20170681
    [Abstract] [Full Text] [Related]

  • 12. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
    Chu JH, Chiang CC, Ng ML.
    J Immunol; 2007 Mar 01; 178(5):2699-705. PubMed ID: 17312111
    [Abstract] [Full Text] [Related]

  • 13. Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
    Escribano-Romero E, Gamino V, Merino-Ramos T, Blázquez AB, Martín-Acebes MA, de Oya NJ, Gutiérrez-Guzmán AV, Escribano JM, Höfle U, Saiz JC.
    Vaccine; 2013 Sep 23; 31(41):4523-7. PubMed ID: 23933372
    [Abstract] [Full Text] [Related]

  • 14. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
    Iglesias MC, Frenkiel MP, Mollier K, Souque P, Despres P, Charneau P.
    J Gene Med; 2006 Mar 23; 8(3):265-74. PubMed ID: 16308885
    [Abstract] [Full Text] [Related]

  • 15. Immunization of mice against West Nile virus with recombinant envelope protein.
    Wang T, Anderson JF, Magnarelli LA, Wong SJ, Koski RA, Fikrig E.
    J Immunol; 2001 Nov 01; 167(9):5273-7. PubMed ID: 11673542
    [Abstract] [Full Text] [Related]

  • 16. Persistence of antibodies to West Nile virus nonstructural protein 5.
    Prince HE, Lapé-Nixon M, Yeh C, Tobler LH, Busch MP.
    J Clin Virol; 2008 Sep 01; 43(1):102-6. PubMed ID: 18467165
    [Abstract] [Full Text] [Related]

  • 17. Serologic diagnosis of West Nile virus infection.
    Shi PY, Wong SJ.
    Expert Rev Mol Diagn; 2003 Nov 01; 3(6):733-41. PubMed ID: 14628901
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
    Ohtaki N, Takahashi H, Kaneko K, Gomi Y, Ishikawa T, Higashi Y, Kurata T, Sata T, Kojima A.
    Vaccine; 2010 Sep 14; 28(40):6588-96. PubMed ID: 20678586
    [Abstract] [Full Text] [Related]

  • 19. Expression of recombinant West Nile virus prM protein fused to an affinity tag for use as a diagnostic antigen.
    Setoh YX, Hobson-Peters J, Prow NA, Young PR, Hall RA.
    J Virol Methods; 2011 Jul 14; 175(1):20-7. PubMed ID: 21545809
    [Abstract] [Full Text] [Related]

  • 20. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
    Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, Fremont DH, Hansen TH, Diamond MS.
    Eur J Immunol; 2007 Jul 14; 37(7):1845-54. PubMed ID: 17559174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.